FeaturesSignalPricingFounders
TM

Thomas, McNerney & Partners

Venture CapitalActive

Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management focused on investing in

Stamford, United StatesFounded 2018tm-partners.com
46
Investments
6
Exits
$1.2B
AUM
13.0%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Thomas, McNerney & Partners.

Get started free

Investment Thesis & Strategy

Thomas, McNerney & Partners invests in various stages of life science and healthcare companies, with a focus on those that have the potential to disrupt the healthcare industry.

Investment Activity

Deals per year over the last 14 years

1
2009
0
2010
1
2011
2
2012
2
2013
1
2014
0
2015
0
2016
0
2017
3
2018
0
2019
0
2020
0
2021
2
2022

Portfolio Companies

Selected investments from their portfolio of 46 companies

O
Obsidio
Healthcare · Series A, 2022
Active
S
Sollis Health
Healthcare · Series A, 2022
Active
V
Vascular Therapies
Biotech · Series A, 2018
Active
C
Confluent Health
Healthcare · Growth, 2018
Active
V
Vascular Therapies
Biotech · Series A, 2018
Active
V
Vascular Dynamics
Healthcare · Series B, 2014
Active
B
Biohaven Pharmaceutical
Biotech · Series A, 2013
Active
V
Vapotherm
Healthcare · Series B, 2013
Active
A
Aptus Health
Healthcare · Growth, 2012
Active
X
Xenex Disinfection Services
Healthcare · Growth, 2012
Active
i
iRhythm Technologies
Healthcare · Series B, 2011
Active
V
ViewRay
Healthcare · Series C+, 2009
Active

Notable Exits

CompanyTypeYearValue / Acquirer
athenahealthAcquisition2022$17B
Grand RoundsAcquisition2021$1.9B
Teladoc HealthAcquisition2020$18.5B
Livongo HealthIPO2019$4.4B
Health CatalystIPO2019$1.2B
Castlight HealthIPO2014$3B

Frequently Asked Questions

Thomas, McNerney & Partners focuses on Series A, Series B, Series C+ stage investments.

Related Investors